Equities

Pharma Foods International Co Ltd

2929:TYO

Pharma Foods International Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)887.00
  • Today's Change6.00 / 0.68%
  • Shares traded231.30k
  • 1 Year change-43.03%
  • Beta2.2308
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Jul 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue62,14768,57260,185
OPERATING EXPENSES
Cost of revenue total13,39513,29312,077
Selling, general and admin. expenses, total42,56150,75746,211
Depreciation/amortization997251
Unusual expense(income)22542(82)
Other operating expenses, total1.00----
Total operating expense57,25965,00459,023
Operating income4,8883,5681,162
Other, net20989130
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes5,0343,5421,423
Provision for income taxes1,8284621,797
Net income after taxes3,2063,080(374)
Minority interest--0--
Net income before extra. Items3,2063,080(374)
Total extraordinary items------
Net income3,2063,080(374)
Inc.avail. to common excl. extra. Items3,2053,081(374)
Inc.avail. to common incl. extra. Items3,2053,081(374)
EPS RECONCILIATION
Basic/primary weighted average shares282929
Basic/primary eps excl. extra items113107(13)
Basic/primary eps incl. extra items113107(13)
Dilution adjustment------
Diluted weighted average shares282929
Diluted eps excl. extra items113107(13)
Diluted eps incl. extra items113107(13)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue252220
Gross dividend - common stock--634580
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental624826
SUPPLEMENTAL INCOME
Depreciation, supplemental808474469
Total special items324120(108)
NORMALISED INCOME
Normalized income before taxes5,3583,6621,315
Effect of special items on income taxes826.26(56)
Income tax excluding impact of special items1,9104681,741
Normalized income after tax3,4483,194(426)
Normalized income avail. to common3,4473,195(426)
Basic normalized EPS121111(15)
Diluted normalized EPS121111(15)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.